心力衰竭中的神经调节疗法：药物与设备的联合应用
Neuromodulation Therapy in Heart Failure: Combined Use of Drugs and Devices.
作者信息
Sobowale Christopher O, Hori Yuichi, Ajijola Olujimi A
机构信息
UCLA Cardiac Arrhythmia Center, UCLA Neurocardiology Research Center, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Department of Cardiology, Dokkyo Medical University Saitama Medical Center, Saitama, Japan.
出版信息
J Innov Card Rhythm Manag. 2020 Jul 15;11(7):4151-4159. doi: 10.19102/icrm.2020.110705. eCollection 2020 Jul.
Abstract
Heart failure (HF) is the fastest-growing cardiovascular disease globally. The autonomic nervous system plays an important role in the regulation and homeostasis of cardiac function but, once there is HF, it takes on a detrimental role in cardiac function that makes it a rational target. In this review, we cover the remodeling of the autonomic nervous system in HF and the latest treatments available targeting it.
摘要
心力衰竭（HF）是全球增长最快的心血管疾病。自主神经系统在心脏功能的调节和稳态中发挥着重要作用，但一旦发生心力衰竭，它就会对心脏功能产生有害作用，这使其成为一个合理的治疗靶点。在本综述中，我们涵盖了心力衰竭中自主神经系统的重塑以及针对该系统的最新可用治疗方法。
相似文献
1
Neuromodulation Therapy in Heart Failure: Combined Use of Drugs and Devices.
J Innov Card Rhythm Manag. 2020 Jul 15;11(7):4151-4159. doi: 10.19102/icrm.2020.110705. eCollection 2020 Jul.
2
Neuromodulation Approaches for Cardiac Arrhythmias: Recent Advances.
Curr Cardiol Rep. 2019 Mar 18;21(5):32. doi: 10.1007/s11886-019-1120-1.
3
Calming the Nervous Heart: Autonomic Therapies in Heart Failure.
Card Fail Rev. 2018 Aug;4(2):92-98. doi: 10.15420/cfr.2018.20.2.
4
Neuromodulation interventions in the management of heart failure.
Eur J Heart Fail. 2024 Feb;26(2):502-510. doi: 10.1002/ejhf.3147. Epub 2024 Jan 21.
5
Autonomic regulation therapy for the improvement of left ventricular function and heart failure symptoms: the ANTHEM-HF study.
J Card Fail. 2013 Sep;19(9):655-60. doi: 10.1016/j.cardfail.2013.07.002.
6
Sympathetic nervous system activation and heart failure: Current state of evidence and the pathophysiology in the light of novel biomarkers.
World J Cardiol. 2020 Aug 26;12(8):373-408. doi: 10.4330/wjc.v12.i8.373.
7
Extended Follow-Up of Patients With Heart Failure Receiving Autonomic Regulation Therapy in the ANTHEM-HF Study.
J Card Fail. 2016 Aug;22(8):639-42. doi: 10.1016/j.cardfail.2015.11.002. Epub 2015 Nov 11.
8
Cardiac resynchronization therapy restores sympathovagal balance in the failing heart by differential remodeling of cholinergic signaling.
Circ Res. 2015 May 8;116(10):1691-9. doi: 10.1161/CIRCRESAHA.116.305268. Epub 2015 Mar 2.
9
Stimulation of ganglionated plexus attenuates cardiac neural remodeling and heart failure progression in a canine model of acute heart failure post-myocardial infarction.
Auton Neurosci. 2017 Dec;208:73-79. doi: 10.1016/j.autneu.2017.09.013. Epub 2017 Sep 18.
10
Bionic autonomic neuromodulation revolutionizes cardiology in the 21st century.
Annu Int Conf IEEE Eng Med Biol Soc. 2009;2009:2043-5. doi: 10.1109/IEMBS.2009.5334435.
引用本文的文献
1
Device therapies for heart failure with reduced ejection fraction: a new era.
Front Cardiovasc Med. 2024 Oct 18;11:1388232. doi: 10.3389/fcvm.2024.1388232. eCollection 2024.
2
Transcatheter interventions for heart failure.
EuroIntervention. 2023 Feb 20;18(14):1135-1149. doi: 10.4244/EIJ-D-22-00070.
3
Reflecting on the advancements of HFrEF therapies over the last two decades and predicting what is yet to come.
Eur Heart J Suppl. 2022 Dec 19;24(Suppl L):L2-L9. doi: 10.1093/eurheartjsupp/suac112. eCollection 2022 Dec.
4
Modern Approaches for the Treatment of Heart Failure: Recent Advances and Future Perspectives.
Pharmaceutics. 2022 Sep 17;14(9):1964. doi: 10.3390/pharmaceutics14091964.
5
Device Therapy in Chronic Heart Failure: JACC State-of-the-Art Review.
J Am Coll Cardiol. 2021 Aug 31;78(9):931-956. doi: 10.1016/j.jacc.2021.06.040.
本文引用的文献
1
TREAT AF (Transcutaneous Electrical Vagus Nerve Stimulation to Suppress Atrial Fibrillation): A Randomized Clinical Trial.
JACC Clin Electrophysiol. 2020 Mar;6(3):282-291. doi: 10.1016/j.jacep.2019.11.008. Epub 2020 Jan 29.
2
Comparison of symptomatic and functional responses to vagus nerve stimulation in ANTHEM-HF, INOVATE-HF, and NECTAR-HF.
ESC Heart Fail. 2020 Feb;7(1):75-83. doi: 10.1002/ehf2.12592. Epub 2020 Jan 27.
3
Effect of Renal Denervation and Catheter Ablation vs Catheter Ablation Alone on Atrial Fibrillation Recurrence Among Patients With Paroxysmal Atrial Fibrillation and Hypertension: The ERADICATE-AF Randomized Clinical Trial.
JAMA. 2020 Jan 21;323(3):248-255. doi: 10.1001/jama.2019.21187.
4
New approaches for treating atrial fibrillation: Focus on autonomic modulation.
Trends Cardiovasc Med. 2020 Oct;30(7):433-439. doi: 10.1016/j.tcm.2019.10.009. Epub 2019 Oct 31.
5
Renal denervation as adjunctive therapy to cardiac sympathetic denervation for ablation refractory ventricular tachycardia.
Heart Rhythm. 2020 Feb;17(2):220-227. doi: 10.1016/j.hrthm.2019.09.016. Epub 2019 Sep 17.
6
Cardiac sympathetic denervation for refractory ventricular arrhythmias in patients with structural heart disease: A systematic review.
Heart Rhythm. 2019 Oct;16(10):1499-1505. doi: 10.1016/j.hrthm.2019.06.018. Epub 2019 Jun 25.
7
Economic Impact of Chronic Heart Failure Management in Today's Cost-Conscious Environment.
Card Electrophysiol Clin. 2019 Mar;11(1):1-9. doi: 10.1016/j.ccep.2018.11.002. Epub 2018 Dec 22.
8
Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association.
Circulation. 2019 Mar 5;139(10):e56-e528. doi: 10.1161/CIR.0000000000000659.
9
Cardiac contractility modulation: mechanisms of action in heart failure with reduced ejection fraction and beyond.
Eur J Heart Fail. 2019 Jan;21(1):14-22. doi: 10.1002/ejhf.1349. Epub 2018 Nov 28.
10
Renal Denervation Prevents Heart Failure Progression Via Inhibition of the Renin-Angiotensin System.
J Am Coll Cardiol. 2018 Nov 27;72(21):2609-2621. doi: 10.1016/j.jacc.2018.08.2186.
Zotero 插件